FAQ  /  Metabolic Health

What Are Exercise Mimetics, and Does the Evidence Hold Up?

Where the Term Comes From

---

It was coined in a 2008 paper in Cell titled "AMPK and PPARδ agonists are exercise mimetics." The authors gave sedentary mice four weeks of an oral AMPK activator with no training at all, and running endurance rose 44 percent (Narkar et al. 2008). That result opened a question metabolic research is still working on: how much of the adaptation to endurance training can be reached by activating the signaling directly.

What the Term Does and Does Not Mean

---

Exercise is not a single signal. It is mechanical loading of muscle and bone, shear stress across the endothelium, repeated calcium flux, substrate depletion, a rise in core temperature, and a systemic endocrine response, all arriving together and repeating over years. Out of that combined input, the cell runs a coordinated adaptation program with PGC-1α near its center.

An exercise mimetic activates one node inside that program. The node is real and so is the effect downstream of it. But activating one arm of an adaptation is not the same as delivering the stimulus that normally triggers all of it, and none of these compounds loads a tendon, remodels bone, or raises stroke volume. The accurate reading of the term is that these compounds share a pathway with exercise, not that they stand in for it.

MOTS-c

---

MOTS-c has the strongest human trajectory of the three. It is a 16-amino-acid peptide encoded inside the mitochondrial genome itself, and it activates AMPK, the same energy sensor from the 2008 paper, through its own distinct mechanism. Its levels rise sharply in muscle and blood with exertion in both mice and people, and lower circulating levels track with worse cardiometabolic disease. A modified analog of MOTS-c significantly improved liver enzymes and fasting glucose against placebo in a completed randomized trial, and a randomized placebo-controlled Phase 2a trial of MOTS-c itself is now enrolling adults with prediabetes. Within a couple of years this will be the first of the three with a real human answer.

SLU-PP-332

---

SLU-PP-332 sits closest to the switch the whole concept is built on. It directly activates all three ERR receptors, which sit immediately downstream of PGC-1α, so it is triggering the exercise adaptation program about as close to its origin as a drug currently can. In mice it raised running duration by roughly 70 percent and distance by roughly 45 percent, and a 2025 study from a group unconnected to the discovering lab found comparable effects in muscle precursor cells taken from elderly patients, the first evidence in human tissue. There are no completed or registered human trials of any phase, and the compound is not orally absorbed, so anything sold as an oral capsule is not delivering what was studied.

5-Amino-1MQ

---

5-Amino-1MQ comes at the same problem from the NAD+ side. It is a small molecule rather than a peptide, grouped with peptide therapies by how it is used clinically. It inhibits NNMT, the enzyme that diverts nicotinamide away from NAD+ synthesis, which leaves more nicotinamide available for NAD+ and spares the methyl donor pool at the same time. Its exercise-mimetic framing comes from muscle aging work, including a 2024 study reporting improved grip strength and exercise-like effects in aged animals. No human trial of the compound has been completed.

How to Think About All Three

---

The biology is real, the pathways are the ones exercise uses, and these are good questions to be asking. What has not been shown is that any of them replaces training in a person. The person who gets something out of these is the one already doing the work, where the compound may help an adaptation along that training is already driving. Asked to do the work instead, they are being asked for something no study has shown they can deliver. Anyone selling them on that promise, particularly the research chemicals marketed online under the same phrase, is selling ahead of the evidence.

Dr. Darrell Wilcox · @wellnessdoc_4everyoung on Instagram

This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Exercise mimetics are an area of active research, and this page is a general explainer, not guidance for any specific supplement, test, or treatment decision. Individual questions about labs, symptoms, or treatment should be directed to your treating clinician. Dr. Wilcox is licensed to practice in multiple states. See About for current licensure.